Living specs make audit trails a byproduct of normal work: every requirement change is captured as a diff, with an author, a timestamp, a rationale, and an approval, inside the document itself. That structure satisfies much of the traceability regulators actually ask for — but it supports, rather than replaces, your formal compliance program.
Quick answer: A living spec's diff-and-approval history — who changed what, why, and who signed off — is close to the change-attribution record that
PCI DSS,SOC 2, and FDA design-control audits ask for. Treat it as strong supporting evidence, not a substitute for your compliance program's formal controls.
In fintech and health, "who changed this requirement and why" isn't a nice-to-have thread in a chat archive — it's an audit line item, and someone eventually has to answer it under scrutiny. Most product teams discover this the hard way: an examiner asks for the history behind a control, and the honest answer is a scavenger hunt across a wiki, a Slack channel, and somebody's memory.
Living specs close that gap natively, because the audit trail is the same artifact the team already uses to do the work.
Why "Who Changed This and Why" Is a Named Compliance Control
In fintech, health, and other regulated verticals, change history isn't a courtesy — it's a named control. Frameworks like FDA design controls, PCI DSS, SOC 2, and the Federal Reserve's SR 11-7 model risk guidance all require documented rationale and approval for changes that affect a validated system, product, or model.
None of these frameworks were written with product requirement documents in mind. But every one of them cares about the same underlying question a spec's history can answer: what changed, who decided it, and what evidence backs the decision.
The Frameworks That Already Ask for This
- FDA design controls (
21 CFR Part 820.30), which require a Design History File tracing every requirement to its verification and validation evidence, including a record of changes. PCI DSS, whose change-management requirement calls for documented approval, testing, and a rollback plan before any change touching cardholder-data systems reaches production.SOC 2's change-management criterion (CC8.1in the AICPA Trust Services Criteria), which expects organizations to authorize, test, approve, and document changes to infrastructure and software.SR 11-7, the Federal Reserve and OCC's model risk management guidance, which requires documented rationale and revalidation whenever a risk-scoring or pricing model changes.
The common thread: none of these ask a team to recreate history from memory during an audit. They ask a team to produce it. A living spec turns that production step into something that already exists, rather than a fire drill triggered by an audit notice. For the broader model this article builds on, the living specs complete guide covers how a spec becomes a continuously-updated document instead of a point-in-time deliverable.
How the Diff-and-Approval Model Becomes an Audit Trail
Every change to a living spec produces three things an auditor can use directly: an attributed diff (who changed which line, when), an inline rationale (why), and a recorded approval (who signed off, under what review). Together they form a change log that reads like a controlled document, not a chat thread.
Attribution is the easiest part to get right, and the part static docs get wrong most often. A Google Doc's version history shows that something changed; it rarely shows which requirement changed in a way you could cite in an audit response. A living spec's diff is scoped to the requirement itself, so the attribution is precise rather than approximate.
Rationale is the part teams skip under deadline pressure — and the part auditors care about most. A diff that only shows old value versus new value answers "what changed" but not "why," and "why" is usually the actual audit question. Making a rationale field structurally required, not optional, is what closes this gap.
This is the same review discipline covered in how PR-style spec diffs work for review — treating a requirement change the way engineering already treats a code change, with a description that has to justify the diff before anyone approves it.
Sign-off completes the trail. A reviewer approving a diff, by name, with a timestamp, is functionally identical to a controlled document's signature block — it just happens inside the tool people are already using.
A version-history log answers "what changed." An audit trail has to answer "what changed, why, and who said yes." Most PRD tools give you the first. A diff-and-approval workflow gives you all three, without a separate process.
| Audit question | Static PRD (doc/wiki) | Living spec (diff + approval) |
|---|---|---|
| Who changed this requirement? | Buried in "last edited by," often the last editor, not necessarily the decision-maker | Attributed to the author of that specific change |
| When did it change? | Approximate, from document metadata | Timestamped per change, at the requirement level |
| Why did it change? | Usually in a Slack thread, if it exists anywhere | Captured inline with the diff itself |
| Who approved it? | Implicit, rarely recorded as a discrete event | Explicit reviewer approval, recorded as part of the change |
| Can you reconstruct the state as of a given date? | Manual reconstruction from doc revision history | A version snapshot exists as a natural byproduct |
The table above isn't an argument that static docs are unusable — teams have shipped regulated products from Word documents for decades. It's an argument that the reconstruction cost during an audit is where the two approaches diverge, and that cost compounds with every change nobody documented in the moment.
Traceability: Connecting Requirement, Test, and Release
Traceability means every requirement change links forward to the test cases that verify it and the release that ships it, and backward to the discussion that justified it. Living specs make this a structural property — each requirement carries an ID that test cases and release notes can reference — rather than a spreadsheet assembled after the fact.
What a Traceability Matrix Actually Links
Medical device software regulation is explicit about this. IEC 62304, the software lifecycle standard most device software gets assessed against, and ISO 13485, the quality management standard around it, both expect a requirements traceability matrix (RTM) connecting:
- A requirement — the thing the system is supposed to do.
- The design or spec change that implements or modifies it.
- The test case that verifies it.
- The release that ships it.
Fintech doesn't have an identical named mandate, but examiners under frameworks like SR 11-7 and PCI DSS expect the same lineage in practice: a control requirement that changed, tested, and shipped without a documented trail is a finding waiting to happen, regardless of which regulator is asking.
A living spec doesn't build the RTM for you as a separate deliverable — it makes the requirement itself the anchor everything else attaches to. As a requirement section matures from a rough draft into a locked, implementation-ready state, that maturity marker becomes part of the same lineage; see section-level maturity in a living spec for how that grading works structurally.
A requirement shouldn't reach engineering until it's actually ready, and the same traceability logic is what a ready-to-start versus ready-to-ship gate enforces — a change can't reach a shippable state without its test links closed out.
A Fintech Example: Raising a Daily Transaction Limit
Consider a neobank raising its daily ACH transfer limit for verified customers from $2,500 to $5,000. That single-line requirement change touches fraud scoring, Bank Secrecy Act reporting thresholds, and support scripts — exactly the kind of change regulators expect to see documented, reviewed, and traceable to test evidence before release.
Here's what the living spec captures at each step:
- The diff. The requirement section is rewritten inline: old value $2,500, new value $5,000, scoped to Tier-2 verified accounts.
- The rationale. The diff carries a comment explaining the change: declined transfers above the old limit were generating a disproportionate share of support contacts from otherwise legitimate high-value customers. This is exactly the kind of moment a customer journey emotion curve is built to surface — the decline-and-call-support loop a $2,500 cap creates for a customer trying to make a large, legitimate transfer.
- The reviewers. Compliance (BSA/AML exposure), the fraud/model risk owner (whether the scoring model was validated at the new threshold, per
SR 11-7), and an engineering lead all review the same diff. - Their job to be done. A compliance officer's job here isn't "help ship the feature" — it's closer to "give me evidence this won't create an unmonitored risk." That's a distinct job worth mapping with the same rigor as a customer's, which is the premise behind mapping jobs to be done for any stakeholder whose approval gates a release.
- The approval. Each reviewer signs off on the same diff, by name, with a timestamp — not a separate email chain running in parallel.
- The traceability. The requirement ID links to the specific test cases that verify it and the release that ships it.
| Requirement ID | Change | Approvers | Linked test cases | Release |
|---|---|---|---|---|
| REQ-114 | Daily transfer limit: $2,500 → $5,000, Tier-2 verified accounts | Compliance (BSA/AML), Risk (model revalidation), Eng lead | TC-114a limit enforcement; TC-114b fraud score threshold; TC-114c SAR trigger regression | v4.2.0 |
When an examiner later asks who approved raising the limit, and whether the fraud model was revalidated at the new threshold, the answer is one query into the spec's history — not a reconstruction project across email, Slack, and a separate test-management tool.
Where Living Specs Stop and Formal Compliance Starts
A living spec's change history is strong supporting evidence. It is not itself a validated quality system, an FDA submission, or a SOC 2 report. It won't enforce segregation of duties, retention schedules, or electronic-signature requirements on its own, so treat it as an input to compliance, not a replacement for it.
What a Living Spec Can't Do for You
21 CFR Part 11electronic-record and signature requirements have specific validation and audit-trail-immutability expectations. A spec tool having diffs doesn't automatically satisfy them — that takes deliberate validation of the system itself.- Retention schedules for regulated records (SEC/FINRA broker-dealer requirements, HIPAA documentation rules, and similar regimes) are usually longer, and more specifically defined, than a product team's default archive policy.
- Segregation of duties — requiring the approver to be organizationally distinct from the author — is a policy your compliance or QA function has to define and enforce. A spec tool can support the workflow; it can't invent the policy.
A diff trail proves what changed inside the document. It doesn't prove the document was the system of record, that access was controlled, or that the change followed your SOP — that's still on your quality and compliance functions to establish.
The honest framing: a living spec is where the decision gets documented well. Whether that documentation satisfies a specific regulator's evidentiary bar is a question for your compliance, quality, or legal function — not something a product tool can certify on your behalf.
Building an Audit-Ready Living Spec Workflow
An audit-ready living spec workflow needs four things: mandatory rationale fields, named reviewers routed by change type, requirement IDs that test cases and releases can reference, and the ability to reconstruct any past state of the spec. None of this requires a separate audit tool — it requires making these fields structural rather than optional.
- Make rationale non-optional. A diff without a "why" doesn't get merged, the same way a pull request without a description shouldn't get approved.
- Route reviewers by change type. A change to a risk threshold or reporting trigger should route to compliance or risk automatically, not depend on someone remembering to loop them in.
- Give every requirement a stable ID that test cases, engineering tickets, and release notes can all reference back to.
- Keep every version, not just the latest. The audit test is "reconstruct the spec as of a specific date," not "show me what it looks like now."
- Separate readiness to build from readiness to ship, so a change can't reach production with its traceability links still open.
This is the problem Spec Studio, inside Prodinja's prototype, is built around: a living PRD structured as PR-style diffs, where each change carries its author, its rationale, and its reviewer sign-off inside the spec itself, rather than scattered across Slack threads and email. It's designed to give regulated teams the kind of attributed, diff-based change record described throughout this article — capturing what changed and why inside the spec itself, as one input into a compliance program, not a replacement for the formal one your regulator already expects.
Key Takeaways
- Regulated frameworks already name this requirement. FDA design controls,
PCI DSS,SOC 2 CC8.1, andSR 11-7all expect documented rationale and approval for changes to validated systems. - A diff-and-approval workflow produces attribution, rationale, and sign-off as a byproduct of normal spec work, not as a separate audit-prep exercise.
- Traceability means linking a requirement forward to its test cases and release, and backward to the discussion that justified it — the same lineage
IEC 62304andISO 13485expect from a formal RTM. - A fintech limit change is a useful test case: it needs documented rationale, multi-role approval (compliance, risk, engineering), and traceable test evidence before it ships.
- Living specs support compliance; they don't replace it. Retention schedules,
21 CFR Part 11signature validation, and segregation-of-duties policy still belong to your quality and compliance functions. - Making rationale and reviewer routing structural — not optional — is what actually makes a spec audit-ready, more than any single tool choice.
Frequently Asked Questions
Do living specs satisfy FDA or PCI DSS audit requirements on their own?
No. A living spec's diff-and-approval history generates strong evidence — attribution, rationale, and sign-off — but it doesn't replace a formal Design History File, a validation protocol, or a QSA-assessed control environment. Those still require your compliance and quality functions to formally establish and certify.
What's the difference between a requirements traceability matrix and a living spec's diff history?
A traceability matrix (RTM), as expected under IEC 62304 or ISO 13485, is typically a deliverable assembled to show a snapshot of requirement-to-test lineage. A living spec's diff history is continuously generated as a byproduct of normal work, so the lineage exists before anyone needs to assemble it for an audit.
Can a living spec replace 21 CFR Part 11 electronic signature requirements?
No. 21 CFR Part 11 has specific requirements around audit-trail immutability and system validation for electronic signatures to count as a legal equivalent of a handwritten one. A general-purpose spec tool having reviewer approvals doesn't automatically meet that bar without deliberate validation of the system itself.
How long should you keep spec version history for audit purposes?
It depends on your regulator's retention rules, not on your tool's defaults — broker-dealer, health, and banking retention requirements all differ, and can run into years rather than sprints. Set retention based on your compliance function's documented policy, then confirm your spec tool actually preserves history for that long.
Who should approve a regulated requirement change — the PM or compliance?
Both, in sequence, not as alternatives. A PM or engineering lead approves for scope and feasibility; compliance or risk approves for regulatory exposure. A living spec workflow should route a regulated change to both roles rather than treating either approval as sufficient on its own.